201 related articles for article (PubMed ID: 8537685)
1. Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma.
Mikloska Z; Kesson AM; Penfold ME; Cunningham AL
J Infect Dis; 1996 Jan; 173(1):7-17. PubMed ID: 8537685
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes.
Mikloska Z; Cunningham AL
J Gen Virol; 1998 Feb; 79 ( Pt 2)():353-61. PubMed ID: 9472620
[TBL] [Abstract][Full Text] [Related]
3. Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.
Cunningham AL; Noble JR
J Clin Invest; 1989 Feb; 83(2):490-6. PubMed ID: 2464000
[TBL] [Abstract][Full Text] [Related]
4. CD8 CTL from genital herpes simplex lesions: recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells.
Koelle DM; Chen HB; Gavin MA; Wald A; Kwok WW; Corey L
J Immunol; 2001 Mar; 166(6):4049-58. PubMed ID: 11238653
[TBL] [Abstract][Full Text] [Related]
5. Monophosphoryl lipid A and QS21 increase CD8 T lymphocyte cytotoxicity to herpes simplex virus-2 infected cell proteins 4 and 27 through IFN-gamma and IL-12 production.
Mikloska Z; Rückholdt M; Ghadiminejad I; Dunckley H; Denis M; Cunningham AL
J Immunol; 2000 May; 164(10):5167-76. PubMed ID: 10799875
[TBL] [Abstract][Full Text] [Related]
6. Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled.
Tigges MA; Leng S; Johnson DC; Burke RL
J Immunol; 1996 May; 156(10):3901-10. PubMed ID: 8621929
[TBL] [Abstract][Full Text] [Related]
7. Modulation of CD8+ CTL effector function by fibroblasts derived from the immunoprivileged cornea.
Knickelbein JE; Divito S; Hendricks RL
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2194-202. PubMed ID: 17460279
[TBL] [Abstract][Full Text] [Related]
8. Effective suppression of class I major histocompatibility complex expression by the US11 or ICP47 genes can be limited by cell type or interferon-gamma exposure.
Radosevich TJ; Seregina T; Link CJ
Hum Gene Ther; 2003 Dec; 14(18):1765-75. PubMed ID: 14670127
[TBL] [Abstract][Full Text] [Related]
9. T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction.
Schnyder B; Frutig K; Mauri-Hellweg D; Limat A; Yawalkar N; Pichler WJ
Clin Exp Allergy; 1998 Nov; 28(11):1412-7. PubMed ID: 9824415
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of interferon-gamma in intraocular herpes simplex type 1 infection do not depend on major histocompatibility complex class I or class II expression.
Geiger KD; Lee MS; Baugh C; Sarvetnick NE
J Neurovirol; 1995 Dec; 1(5-6):405-9. PubMed ID: 9222384
[TBL] [Abstract][Full Text] [Related]
11. Human keratinocyte induction of rapid effector function in antigen-specific memory CD4+ and CD8+ T cells.
Black AP; Ardern-Jones MR; Kasprowicz V; Bowness P; Jones L; Bailey AS; Ogg GS
Eur J Immunol; 2007 Jun; 37(6):1485-93. PubMed ID: 17506032
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte-mediated activation of cultured endothelial cells (EC). CD4+ T cells inhibit EC class II MHC expression despite secreting IFN-gamma and increasing EC class I MHC and intercellular adhesion molecule-1 expression.
Doukas J; Pober JS
J Immunol; 1990 Aug; 145(4):1088-98. PubMed ID: 1974272
[TBL] [Abstract][Full Text] [Related]
13. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
Homma S; Komita H; Sagawa Y; Ohno T; Toda G
Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus antigens directly activate NK cells via TLR2, thus facilitating their presentation to CD4 T lymphocytes.
Kim M; Osborne NR; Zeng W; Donaghy H; McKinnon K; Jackson DC; Cunningham AL
J Immunol; 2012 May; 188(9):4158-70. PubMed ID: 22467654
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of herpes simplex virus-specific CD4+ T cells in corneas of herpetic stromal keratitis patients.
Verjans GM; Remeijer L; van Binnendijk RS; Cornelissen JG; Völker-Dieben HJ; Baarsma SG; Osterhaus AD
J Infect Dis; 1998 Feb; 177(2):484-8. PubMed ID: 9466544
[TBL] [Abstract][Full Text] [Related]
16. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
Srivastava R; Khan AA; Garg S; Syed SA; Furness JN; Vahed H; Pham T; Yu HT; Nesburn AB; BenMohamed L
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847359
[TBL] [Abstract][Full Text] [Related]
17. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
Yasukawa M; Zarling JM
J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G
Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521
[TBL] [Abstract][Full Text] [Related]
19. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D
Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694
[TBL] [Abstract][Full Text] [Related]
20. Functional heterogeneity among herpes simplex virus-specific human CD4+ T cells.
Yasukawa M; Inatsuki A; Horiuchi T; Kobayashi Y
J Immunol; 1991 Feb; 146(4):1341-7. PubMed ID: 1671404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
